Geron reported $49M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Amgen USD 9.18B 1.03B Jun/2025
Bio Techne USD 317M 820K Jun/2025
Cassava Sciences 0 0 Dec/2024
Cytokinetics USD 66.76M 65.16M Jun/2025
Exelixis USD 568.3M 12.9M Jun/2025
Genmab DKK 5.86B 580M Jun/2025
Geron USD 49M 9.4M Jun/2025
Gilead Sciences USD 7.1B 430M Jun/2025
Incyte USD 1.06B 10M Jun/2025
MacroGenics USD 22.24M 2.89M Jun/2025
Novartis USD 14.05B 821M Jun/2025